Eurofins Scientific SE (EPA:ERF)
64.58
-1.08 (-1.64%)
At close: Mar 6, 2026
Eurofins Scientific SE Revenue
In the year 2025, Eurofins Scientific SE had annual revenue of 7.30B EUR with 4.96% growth. Eurofins Scientific SE had revenue of 3.68B in the half year ending December 31, 2025, with 11.47% growth.
Revenue
7.30B
Revenue Growth
+4.96%
P/S Ratio
1.56
Revenue / Employee
111.06K
Employees
65,694
Market Cap
11.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.30B | 345.10M | 4.96% |
| Dec 31, 2024 | 6.95B | 436.40M | 6.70% |
| Dec 31, 2023 | 6.51B | -197.50M | -2.94% |
| Dec 31, 2022 | 6.71B | -5.60M | -0.08% |
| Dec 31, 2021 | 6.72B | 1.28B | 23.51% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 28.49B |
| Sanofi | 46.72B |
| Sartorius Stedim Biotech | 2.97B |
| Ipsen | 3.93B |
| bioMérieux | 4.07B |
| ABIVAX Société Anonyme | 5.31M |
| Virbac | 1.43B |
| emeis Société anonyme | 5.77B |
Eurofins Scientific SE News
- 20 days ago - Eurofins Scientific : Director/PDMR Shareholding - Business Wire
- 26 days ago - Eurofins Scientific: Director/PDMR Shareholding - Business Wire
- 27 days ago - Eurofins Scientific SE: Weekly Report on Share Repurchases from 02nd February to 06th February 2026 • news - Onvista
- 5 weeks ago - Eurofins Scientific SE (ERFSF) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Eurofins Scientific SE: Director/PDMR Shareholding - Business Wire
- 3 months ago - Eurofins Scientific SE: Director/PDMR Shareholding - Business Wire
- 4 months ago - Eurofins Scientific: Growth, Repurchase Program, And Low Debt Make An Excellent Combination - Seeking Alpha
- 4 months ago - Eurofins Scientific SE (ERFSF) Q3 2025 Sales Call Transcript - Seeking Alpha